• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

mRNA SARS-CoV-2 疫苗首剂接种后 2 周发生脑静脉窦血栓。

Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine.

机构信息

Department of Neurosciences, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150, Kota Bharu, Kelantan, Malaysia.

Hospital Universiti Sains Malaysia, Universiti Sains Malaysia, Health Campus, Jalan Raja Perempuan Zainab 2, 16150, Kota Bharu, Kelantan, Malaysia.

出版信息

Acta Neurochir (Wien). 2021 Aug;163(8):2359-2362. doi: 10.1007/s00701-021-04860-w. Epub 2021 Jun 8.

DOI:10.1007/s00701-021-04860-w
PMID:34101024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8186353/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as coronavirus disease 2019 (COVID-19) is a highly transmissible virus and has become pandemic. Part of the prevention of disease spread by the Malaysian government is by getting COVID-19 vaccine. Using the mRNA technology, the Pfizer/BioNTech vaccine is one of the vaccines been approved by the Drug Control Authority in Malaysia. Herein, we report an immediate complication of cerebral VST after the first dose of the Pfizer/BioNTech vaccine.

摘要

严重急性呼吸综合征冠状病毒 2（SARS-CoV-2），也称为 2019 年冠状病毒病（COVID-19），是一种高度传染性病毒，已在全球流行。马来西亚政府防止疾病传播的措施之一是接种 COVID-19 疫苗。辉瑞/生物科技公司的疫苗使用信使 RNA 技术，是马来西亚药品管制局批准使用的疫苗之一。在此，我们报告首例接种辉瑞/生物科技公司疫苗后出现大脑静脉窦血栓形成的即刻并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ba/8186353/a43523d61038/701_2021_4860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ba/8186353/a43523d61038/701_2021_4860_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80ba/8186353/a43523d61038/701_2021_4860_Fig1_HTML.jpg

相似文献

1
Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine.mRNA SARS-CoV-2 疫苗首剂接种后 2 周发生脑静脉窦血栓。
Acta Neurochir (Wien). 2021 Aug;163(8):2359-2362. doi: 10.1007/s00701-021-04860-w. Epub 2021 Jun 8.
2
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
3
Cerebral Venous Thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine.BNT162b2 mRNA SARS-CoV-2 疫苗接种后并发脑静脉血栓形成。
J Stroke Cerebrovasc Dis. 2021 Aug;30(8):105906. doi: 10.1016/j.jstrokecerebrovasdis.2021.105906. Epub 2021 May 25.
4
Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.健康女性在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后发生广泛脑静脉窦血栓形成（CVST），但无血栓性血小板减少综合征（TTS）。
Am J Case Rep. 2022 Feb 9;23:e934744. doi: 10.12659/AJCR.934744.
5
Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation.一名无合并症的老年印度男性在接种新冠疫苗后出现抗PF4抗体阴性的脑静脉窦血栓形成且无血小板减少症，采用基于普通肝素-华法林的抗凝治疗。
Diabetes Metab Syndr. 2021 Jul-Aug;15(4):102184. doi: 10.1016/j.dsx.2021.06.021. Epub 2021 Jun 24.
6
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.mRNA COVID-19 疫苗接种后出现心肌炎报告：免疫实践咨询委员会更新-美国，2021 年 6 月。
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
7
COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.使用两步分级方案管理与 COVID-19 疫苗相关的疑似过敏反应和第二剂接种。
Allergy Asthma Proc. 2021 Nov 1;42(6):515-521. doi: 10.2500/aap.2021.42.210075.
8
Cerebral Venous Sinus Thrombosis in the U.S. Population, After Adenovirus-Based SARS-CoV-2 Vaccination, and After COVID-19.美国人群中基于腺病毒载体的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗接种后及冠状病毒病（COVID-19）后发生的脑静脉窦血栓形成
J Am Coll Cardiol. 2021 Jul 27;78(4):408-411. doi: 10.1016/j.jacc.2021.06.001. Epub 2021 Jun 8.
9
Cerebral venous sinus thrombosis associated with vaccine-induced thrombotic thrombocytopenia.疫苗诱导的血栓性血小板减少性紫癜相关的脑静脉窦血栓形成。
Neuroradiol J. 2022 Apr;35(2):247-249. doi: 10.1177/19714009211036687. Epub 2021 Aug 1.
10
SARS-CoV-2 vaccination associated venous sinus thrombosis in three patients.三例 SARS-CoV-2 疫苗接种相关的静脉窦血栓形成。
J Appl Biomed. 2022 Oct;20(3):83-86. doi: 10.32725/jab.2022.011. Epub 2022 Jul 26.

引用本文的文献

1
Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19.风险效益分析，以评估mRNA新冠疫苗接种后及感染新冠病毒后发生血栓栓塞事件的风险。
NPJ Vaccines. 2024 Sep 13;9(1):166. doi: 10.1038/s41541-024-00960-7.
2
Risk of Blood Clots After COVID-19 Vaccination and Infection: A Risk-Benefit Analysis.新冠病毒疫苗接种和感染后的血栓形成风险：风险效益分析
Res Sq. 2024 Jun 7:rs.3.rs-4378029. doi: 10.21203/rs.3.rs-4378029/v1.
3
Neurovascular Adverse Effects of Sars-Cov-2 Vaccination.Sars-Cov-2 疫苗接种的神经血管不良影响。
Drug Des Devel Ther. 2024 May 30;18:1891-1905. doi: 10.2147/DDDT.S464394. eCollection 2024.
4
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) - Time to think beyond thrombosis with thrombocytopenia syndrome (TTS).基于mRNA的新型冠状病毒2型疫苗（BNT162b2）接种后的血栓形成——是时候超越血小板减少综合征（TTS）相关血栓形成进行思考了。
Thromb Update. 2022 May;7:100104. doi: 10.1016/j.tru.2022.100104. Epub 2022 Apr 18.
5
Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination.新型冠状病毒2感染和新冠疫苗接种后的血液凝固及血栓形成障碍
Biomedicines. 2023 Oct 17;11(10):2813. doi: 10.3390/biomedicines11102813.
6
Management and Characteristics of Embolism and Thrombosis After COVID-19 Vaccination: Scoping Review.新冠疫苗接种后栓塞与血栓形成的管理及特征：范围综述
J Multidiscip Healthc. 2023 Sep 20;16:2745-2772. doi: 10.2147/JMDH.S421291. eCollection 2023.
7
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.2019冠状病毒病疫苗接种后的严重神经系统不良事件：文献综述
Ther Adv Drug Saf. 2023 May 21;14:20420986231165674. doi: 10.1177/20420986231165674. eCollection 2023.
8
Cerebral Venous Sinus Thrombosis Following an mRNA COVID-19 Vaccination and Recent Oral Contraceptive Use.接种mRNA新冠疫苗及近期使用口服避孕药后发生的脑静脉窦血栓形成
Life (Basel). 2023 Feb 7;13(2):464. doi: 10.3390/life13020464.
9
A review of the potential neurological adverse events of COVID-19 vaccines.关于 COVID-19 疫苗潜在神经不良事件的综述。
Acta Neurol Belg. 2023 Feb;123(1):9-44. doi: 10.1007/s13760-022-02137-2. Epub 2022 Nov 16.
10
SARS-CoV-2 vaccination associated venous sinus thrombosis in three patients.三例 SARS-CoV-2 疫苗接种相关的静脉窦血栓形成。
J Appl Biomed. 2022 Oct;20(3):83-86. doi: 10.32725/jab.2022.011. Epub 2022 Jul 26.